￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Possible reactions after discontinuation of tovorafenib and instructions for medication risks and safe discontinuation protocols

2026-02-01 22:25:32

Check Details
How long does it take for vorasidenib-VORANIGO to take effect and analysis of clinical course of treatment, onset of effect and patient experience

2026-02-01 22:25:32

Check Details
Zongatinib (Zongatinib) mechanism of action, pharmacological effects and scientific principles in tumor treatment

2026-02-01 22:25:32

Check Details
Is vosoritide effective for achondroplasia? Analysis of clinical efficacy and patient height improvement data

2026-02-01 22:25:32

Check Details
Methylcobalamin injection (Rozebalamin) latest price reference and application of medical insurance reimbursement policy

2026-02-01 22:25:32

Check Details
Real evaluation of the therapeutic effect of cobimetinib and long-term patient follow-up data

2026-02-01 22:25:32

Check Details
How much does a box of macitentan cost after it is included in medical insurance? List of policy implementation areas

2026-02-01 22:25:32

Check Details
Detailed explanation of the mechanism of action of Tilorisen (Harcos) and its impact on the central arousal system

2026-02-01 22:25:32

Check Details
Pretomanid’s mechanism of action, pharmacological characteristics and scientific analysis of multi-drug-resistant tuberculosis treatment

2026-02-01 22:25:32

Check Details
Tepotinib produces better response in adenocarcinoma versus non-adenocarcinoma MET exon 14 skipped non-small cell lung cancer

2026-02-01 22:25:32

Check Details
Zanzalintinib plus atezolizumab versus regorafenib in previously treated metastatic colorectal cancer without MSI-H or dMMR tumors

2026-02-01 22:25:32

Check Details
What is the specific usage and dosage of pazopanib/vitant?

2026-02-01 22:25:32

Check Details
Category
相关知识